Opendata, web and dolomites

SepsiCare SIGNED

A disruptive multi-sensor chip for fast and effective management of Sepsis at the point of Care

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SepsiCare project word cloud

Explore the words cloud of the SepsiCare project. It provides you a very rough idea of what is the project "SepsiCare" about.

patients    mm2    nearly    small    progression    sensor    patient    device    successful    price    scalable    therapy    yearly    point    volumes    suboptimal    shown    business    guide    time    ml    25    affordable    antimicrobial    diagnose    minutes    competition    solutions    configured    hospitalization    semiconductor    disease    worldwide    treatment    hour    appropriate    mortality    quantify    integrates    starting    antibiotic    photonic    hospitals    relates    ing    poc    rapid    12    million    bacterial    indicators    die    panel    pg    alone    1m    prerequisite    translating    takes    drops    20x20    profitable    clinician    people    offers    sepsis    sensors    biochip    biosensors    unmet    clinical    children    healthcare    monitor    accuracy    infections    30k    billion       reports    accurate    hospital    indicate    concentrations    multiple    blood    sensitive    chip    treating    24    care    chance    lives    started    bacteria    morbidity    until    sepsicare    fast    diagnosis    differentiates    survival    saves    biomarkers   

Project "SepsiCare" data sheet

The following table provides information about the project.

Coordinator
BIALOOM LTD 

Organization address
address: 28TH OCTOVRIOU AVENUE 72 ENGOMI
city: NICOSIA
postcode: 2414
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Cyprus [CY]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIALOOM LTD CY (NICOSIA) coordinator 50˙000.00

Map

 Project objective

SepsiCare project, aims at developing a profitable and scalable business based on SepsiCare integrated biosensors. SepsiCare is an integrated biochip that is capable to provide a set of key patient-condition indicators to the clinician in order to diagnose sepsis, monitor disease progression and assess the effects of treatment within minutes. The SepsiCare device integrates multiple highly sensitive photonic sensors on a low cost 20x20 mm2 semiconductor chip that is configured to quantify a panel of sepsis related biomarkers from small volumes of patient whole blood. What differentiates SepsiCare from the competition is that it offers a multi-sensor test to quantify multiple parameters that indicate sepsis, identify bacteria and guide therapy with high accuracy (concentrations of pg/mL) and at an affordable price (12 Euro per chip). Sepsis affects more than 30 million people worldwide each year and takes 8 million lives including more than 3 million children, translating into healthcare yearly costs nearly $24 billion in the US alone. Starting appropriate and effective antimicrobial treatment is crucial for sepsis survival. Previous reports have shown that the chance of survival drops by 7.6% each hour of disease progression until an appropriate antimicrobial treatment is started. Therefore, achieving an early and accurate diagnosis is a prerequisite for rapid and successful antibiotic therapy. However, point of care (POC) solutions for fast, affordable and effective management of sepsis remains a challenge. The impact of this unmet clinical need to the hospitals relates to the increased time & cost of patient hospitalization (~€30K per sepsis patient). For patients, this has an impact on increased mortality and morbidity (1 in 3 patients of sepsis die) resulting from suboptimal treatment of bacterial infections. By treating just 25% of sepsis patients on time using SepsiCare, a hospital saves up to €1M per year.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SEPSICARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SEPSICARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

INDEXAR (2020)

DEVELOPING A SCALABLE MOBILE AR BROWSER

Read More